HIGHLIGHTS
- who: NASH et al. from the Lund University, Sweden University, Africa have published the research: Identi cation of a potent NAFLD drug candidate for controlling T2DM-mediated in ammation and secondary damage in vitro in vivo, in the Journal: (JOURNAL)
- what: As T2DM and NAFLD exist together like two sides of a coin, hyperglycemia or glucose accumulation is the major reason for the pathogenesis during these conditions. The authors observed that the DMC and KHAG-04 treated animals showed a clear inhibition of phosphorylated ACC in comparison to the control group however the overall ratio . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.